"We are now one of the leading centres in the world for the development of new drug and transplant treatments for patients with blood cancers. This is not only a great benefit to patients in the region but also to the reputation of Birmingham as a home of world-class medicine; in other words this is world-class made in Birmingham."
Professor Charlie Craddock, Co-founder Cure Leukaemia
Cure Leukaemia was established in 2003 to allow patients with blood cancer in our region to access the remarkably effective new treatments which were then becoming available. To celebrate our 10th Anniversary in 2013, long standing supporter Adrian Chiles spoke about 'what we do'...
What makes Cure Leukaemia World-Class?
In 2005, Cure Leukaemia helped secure a grant for £2.2m to build the Centre for Clinical Haematology at the QE Hospital in Birmingham. This has resulted in the development of the second largest adult stem cell transplant programme in the UK, which has been hailed by our Prime Minister, David Cameron as an international centre of excellence in haemato-oncology.
Why the Cure Leukaemia model works
The impact of Cure Leukaemia and the Centre for Clinical Haematology in Birmingham is closely linked to the distinct make-up of the West Midlands region. With a population of 5.5m, and the most ethnically diverse catchment area in Europe, the West Midlands offers access to the broadest possible data pool for drugs trials.
Over the past decade, Cure Leukaemia has funded a network of 15 specialist nurses who work across the West Midlands region to administer pioneering drug treatments to leukaemia patients.
The combination of the unique demographic of the West Midlands and the network of well-supported nurses have enabled us to leverage millions of pounds worth of pioneering drugs and give patients access to clinical trials for drugs not yet readily available on the NHS.
"Charlie Craddock and the team at Cure Leukaemia are a terrific asset for the city. There can surely be no greater cause than saving lives. This particular cause however, also has the added benefit of developing new approaches to clinical care that is providing a new economic force for the city - in life sciences. The city would without doubt be a poorer place without Charlie's passion and vision for this life changing work."
Neil Rami Chief Executive, Marketing Birmingham
Cure Leukaemia's £1m Centre Appeal 2017